These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36202619)

  • 41. Exploration of weekly variation in naloxone possession and carriage among people who use opioids in New York City before, during, and after the COVID-19 pandemic.
    Roth AM; Ward KM; Hensel DJ; Elliott L; Bennett AS
    PLoS One; 2024; 19(7):e0307151. PubMed ID: 39024257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of Analyzing Intervals to Emergency Medical Service Treatments.
    Ornato JP; Dunbar EG; Harbour W; Ludin T; Peberdy MA
    Prehosp Emerg Care; 2023; 27(7):927-933. PubMed ID: 35894873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences.
    Donnell A; Unnithan C; Tyndall J; Hanna F
    Front Public Health; 2022; 10():900733. PubMed ID: 35903371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of overdose in the synthetic opioid era.
    Skolnick P
    Pharmacol Ther; 2022 May; 233():108019. PubMed ID: 34637841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria.
    McDonald R; Strang J
    Addiction; 2016 Jul; 111(7):1177-87. PubMed ID: 27028542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic.
    French R; Favaro J; Aronowitz SV
    Int J Drug Policy; 2021 Aug; 94():103199. PubMed ID: 33765515
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The need for multiple naloxone administrations for opioid overdose reversals: A review of the literature.
    Abdelal R; Banerjee AR; Carlberg-Racich S; Darwaza N; Ito D; Epstein J
    Subst Abus; 2022; 43(1):774-784. PubMed ID: 35112993
    [No Abstract]   [Full Text] [Related]  

  • 49. Medicaid prescription limits and their implications for naloxone accessibility.
    Roberts AW; Look KA; Trull G; Carpenter DM
    Drug Alcohol Depend; 2021 Jan; 218():108355. PubMed ID: 33309522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The innovative role of an "opioid overdose prevention pharmacist" at a mental health teaching hospital.
    Costa T; Zhang M
    Am J Health Syst Pharm; 2021 Feb; 78(4):292-296. PubMed ID: 33471052
    [No Abstract]   [Full Text] [Related]  

  • 51. Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.
    Lambdin BH; Davis CS; Wheeler E; Tueller S; Kral AH
    Drug Alcohol Depend; 2018 Jul; 188():370-376. PubMed ID: 29776688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of the naloxone standing order on trends in opioid fatal overdose: an ecological analysis.
    Taylor M; Pradhan A; Ogando YM; Shaya F
    Am J Drug Alcohol Abuse; 2022 May; 48(3):338-346. PubMed ID: 35467459
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV prevention and treatment strategies can help address the overdose crisis.
    Walley AY
    Prev Med; 2015 Nov; 80():37-40. PubMed ID: 25895840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent Naloxone Dispensing Among Individuals with High-Risk Opioid Prescriptions, USA, 2015-2019.
    Guy GP; Strahan AE; Haegerich T; Losby JL; Ragan K; Evans ME; Jones CM
    J Gen Intern Med; 2021 Oct; 36(10):3254-3256. PubMed ID: 33751410
    [No Abstract]   [Full Text] [Related]  

  • 55. Hostility, compassion and role reversal in West Virginia's long opioid overdose emergency.
    Ondocsin J; Mars SG; Howe M; Ciccarone D
    Harm Reduct J; 2020 Oct; 17(1):74. PubMed ID: 33046092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Rhode Island community responds to opioid overdose deaths.
    Bowman S; Engelman A; Koziol J; Mahoney L; Maxwell C; McKenzie M
    R I Med J (2013); 2014 Oct; 97(10):34-7. PubMed ID: 25271658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia.
    Uzwiak BA; Hudgins A; Pizzicato LN
    Int J Drug Policy; 2021 Nov; 97():103351. PubMed ID: 34252788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the COVID-19 Pandemic on Opioid Overdose Deaths: a Spatiotemporal Analysis.
    Ghose R; Forati AM; Mantsch JR
    J Urban Health; 2022 Apr; 99(2):316-327. PubMed ID: 35181834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The opioid crisis in Canada: a national perspective.
    Belzak L; Halverson J
    Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):224-233. PubMed ID: 29911818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.